3.4M XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 8,400 | 56,562 (0%) | 0% | - | Ordinary Shares | |
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 36,667 | 73,333 | - | - | Restricted Stock Unit | |
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 11,267 | 11,267 | - | - | Restricted Stock Unit | |
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 8,400 | 0 | - | - | Restricted Stock Unit | |
| Peter Fishman | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 31 Jan 2025 | 20,189 | 73,384 (0%) | 0% | 0.6 | 12,517 | Ordinary Shares |
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 36,667 | 93,573 (0%) | 0% | - | Ordinary Shares | |
| Peter Fishman | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 31 Jan 2025 | 6,258 | 56,906 (0%) | 0% | 0.6 | 3,880 | Ordinary Shares |
| Peter Fishman | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 11,267 | 63,164 (0%) | 0% | - | Ordinary Shares | |
| Peter Fishman | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 31 Jan 2025 | 4,665 | 51,897 (0%) | 0% | 0.6 | 2,892 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 19,197 | 709,327 (0%) | 0% | 0.6 | 11,902 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 722,340 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 28,382 | 693,958 (0%) | 0% | 0.6 | 17,597 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 34,566 | 728,524 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 44,933 | 754,260 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 24,833 | 729,427 (0%) | 0% | 0.6 | 15,396 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 38,667 | 768,094 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 21,093 | 747,001 (0%) | 0% | 0.6 | 13,078 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 34,566 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 44,933 | 44,934 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 38,667 | 77,333 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 24,833 | 863,967 (0%) | 0% | 0.6 | 15,396 | Ordinary Shares |
| Aaron D. Berg | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 19,197 | 843,867 (0%) | 0% | 0.6 | 11,902 | Ordinary Shares |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 34,566 | 863,064 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 34,566 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 44,933 | 44,934 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 38,667 | 77,333 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 28,382 | 828,498 (0%) | 0% | 0.6 | 17,597 | Ordinary Shares |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 51,500 | 856,880 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 38,667 | 902,634 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 44,933 | 888,800 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Jan 2025 | 21,093 | 881,541 (0%) | 0% | 0.6 | 13,078 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 663,878 | 663,878 | - | - | Stock Option (right to buy) | |
| Peter Fishman | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 440,475 | 440,475 | - | - | Stock Option (Right to Buy) | |
| Aaron D. Berg | President and CEO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 02 Aug 2024 | 160,000 | 805,380 (0%) | 0% | 0.6 | 102,400 | Ordinary Shares |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 23,883 | 657,143 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 5,000,000 | 5,000,000 | - | - | Stock Option (right to buy) | |
| Aaron D. Berg | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 23,883 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.78 per share. | 31 Jul 2024 | 11,763 | 645,380 (0%) | 0% | 0.8 | 9,175 | Ordinary Shares |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 179,795 | 179,795 | - | - | Stock Option (right to buy) | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 50,287 | 50,287 | - | - | Restricted Stock Unit | |
| Ketchum B. Steven | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 116,000 | 116,000 | - | - | Restricted Stock Unit | |
| Berg D. Aaron | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 418,000 | 418,000 | - | - | Stock Option (right to buy) | |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 418,000 | 418,000 | - | - | Stock Option (right to buy) | |
| Aaron Berg D. | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 116,000 | 116,000 | - | - | Restricted Stock Unit | |
| D. Berg Aaron | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 34,567 | 629,149 (0%) | 0% | - | Ordinary Shares | |
| Aaron Berg D. | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 31 Jan 2024 | 21,954 | 633,260 (0%) | 0% | 1.2 | 27,223 | Ordinary Shares |
| Steven Ketchum B. | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,933 | 681,036 (0%) | 0% | - | Ordinary Shares | |
| Berg Aaron D. | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,933 | 655,214 (0%) | 0% | - | Ordinary Shares | |
| Steven Ketchum B. | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 34,567 | 34,566 | - | - | Restricted Stock Unit | |
| Ketchum B. Steven | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,933 | 89,867 | - | - | Restricted Stock Unit | |
| Berg D. Aaron | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 31 Jan 2024 | 18,868 | 610,281 (0%) | 0% | 1.2 | 23,396 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,933 | 89,867 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 34,567 | 654,974 (0%) | 0% | - | Ordinary Shares | |
| Ketchum Steven B. | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 31 Jan 2024 | 18,871 | 636,103 (0%) | 0% | 1.2 | 23,400 | Ordinary Shares |
| Steven Ketchum B. | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 31 Jan 2024 | 22,316 | 658,720 (0%) | 0% | 1.2 | 27,672 | Ordinary Shares |
| Aaron Berg D. | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 34,567 | 34,566 | - | - | Restricted Stock Unit | |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 22 Jan 2024 | 14,426 | 314,426 (0%) | 0% | 1.1 | 15,724 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 10 Jan 2024 | 28,270 | 620,407 (0%) | 0% | 1.0 | 27,422 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 648,677 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 10 Jan 2024 | 28,214 | 594,582 (0%) | 0% | 1.0 | 27,368 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 51,500 | 622,796 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 14,566 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 14,566 | 604,907 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 04 Jan 2024 | 7,730 | 597,177 (0%) | 0% | 0.9 | 6,725 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 29,133 | 0 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 29,133 | 586,756 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 04 Jan 2024 | 15,460 | 571,296 (0%) | 0% | 0.9 | 13,450 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 47,766 | 613,866 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 47,766 | 47,766 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 29 Dec 2023 | 23,525 | 590,341 (0%) | 0% | 0.9 | 20,467 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 47,766 | 47,766 | - | - | Restricted Stock Unit | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 47,766 | 581,148 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 29 Dec 2023 | 23,525 | 557,623 (0%) | 0% | 0.9 | 20,467 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 12 Dec 2023 | 34,131 | 566,100 (0%) | 0% | 0.8 | 26,963 | Ordinary Shares |
| Jonathan N. Provoost | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 800,000 | 800,000 | - | - | Stock Option (right to buy) | |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 16 Aug 2023 | 30,642 | 194,233 (0%) | 0% | 1.0 | 31,868 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 16 Aug 2023 | 67,222 | 300,000 (0%) | 0% | 1.1 | 71,255 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 16 Aug 2023 | 25,845 | 233,778 (0%) | 0% | 1.1 | 27,266 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 16 Aug 2023 | 12,700 | 206,933 (0%) | 0% | 1.1 | 13,335 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 16 Aug 2023 | 958 | 958 (0%) | 0% | 1.0 | 982 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 16 Aug 2023 | 143,275 | 144,233 (0%) | 0% | 1.0 | 147,573 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 16 Aug 2023 | 19,358 | 163,591 (0%) | 0% | 1.0 | 20,036 | Ordinary Shares |
| Patrick J. Holt | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 5,000,000 | 5,000,000 | - | - | Stock Option (Right to Buy) | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 23,883 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.78 per share. | 31 Jul 2023 | 11,763 | 670,840 (0%) | 0% | 0.8 | 9,175 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 31 Jul 2023 | 11,763 | 600,231 (0%) | 0% | 1.2 | 13,998 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 0 | - | - | Restricted Stock Unit | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 611,994 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 682,603 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 31 Jul 2023 | 11,763 | 533,382 (0%) | 0% | 1.2 | 13,998 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 545,145 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 23,883 | 23,883 | - | - | Restricted Stock Unit | |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 180,804 | 180,804 | - | - | Stock Option (Right to Buy) | |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 60,268 | 60,268 | - | - | Restricted Stock Units | |
| Odysseas D. Kostas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 258,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Keith L. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Mark DiPaolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Patrice Bonfiglio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Oliver O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Paul Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Louis Sterling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 94,866 | 94,866 | - | - | Restricted Stock Units | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 167,411 | 167,411 | - | - | Stock Option (Right to Buy) | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 284,598 | 284,598 | - | - | Stock Option (Right to Buy) | |
| Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 55,804 | 55,804 | - | - | Restricted Stock Units | |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 404,400 | 404,400 | - | - | Stock Option (right to buy) | |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 404,400 | 404,400 | - | - | Stock Option (right to buy) | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 16,333 | 0 | - | - | Restricted Stock Units | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 28 Feb 2023 | 7,718 | 588,111 (0%) | 0% | 2.0 | 15,668 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 16,333 | 595,829 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 28 Feb 2023 | 7,718 | 510,760 (0%) | 0% | 2.0 | 15,668 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 16,333 | 0 | - | - | Restricted Stock Units | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 16,333 | 518,478 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 34,567 | 69,133 | - | - | Restricted Stock Units | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. | 31 Jan 2023 | 13,706 | 564,882 (0%) | 0% | 1.9 | 25,493 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 34,567 | 578,588 (0%) | 0% | - | Ordinary Shares | |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 14,567 | 14,567 | - | - | Restricted Stock Units | |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 134,800 | 134,800 | - | - | Restricted Stock Units | |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 269,600 | 269,600 | - | - | Stock Option (Right to Buy) | |
| Steven B. Ketchum | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share. | 31 Jan 2023 | 14,520 | 579,496 (0%) | 0% | 1.8 | 26,136 | Ordinary Shares |
| Steven B. Ketchum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 29,134 | 594,016 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 29,133 | 29,133 | - | - | Restricted Stock Units | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 34,567 | 69,133 | - | - | Restricted Stock Units | |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 269,600 | 269,600 | - | - | Stock Option (Right to Buy) | |
| Aaron D. Berg | EVP, President US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 34,567 | 485,747 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. | 31 Jan 2023 | 13,707 | 472,040 (0%) | 0% | 1.9 | 25,495 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 58,267 | 530,307 (0%) | 0% | - | Ordinary Shares | |
| Aaron D. Berg | EVP, President US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share. | 31 Jan 2023 | 28,162 | 502,145 (0%) | 0% | 1.8 | 50,692 | Ordinary Shares |
| Aaron D. Berg | EVP, President US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 134,800 | 134,800 | - | - | Restricted Stock Units | |
| Karim Mikhail | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 66,666 | 66,666 | - | - | Restricted Stock Units | |
| Karim Mikhail | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 1,601,500 | 1,601,500 | - | - | Stock Option (Right to Buy) | |
| Karim Mikhail | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 207,700 | 415,400 | - | - | Restricted Stock Units | |
| Karim Mikhail | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share. | 31 Jan 2023 | 10,001 | 283,507 (0%) | 0% | 1.8 | 18,002 | Ordinary Shares |
| Karim Mikhail | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 33,334 | 293,508 (0%) | 0% | - | Ordinary Shares | |
| Karim Mikhail | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. | 31 Jan 2023 | 62,310 | 260,174 (0%) | 0% | 1.9 | 115,897 | Ordinary Shares |
| Karim Mikhail | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 207,700 | 322,484 (0%) | 0% | - | Ordinary Shares | |
| Karim Mikhail | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 800,800 | 800,800 | - | - | Restricted Stock Units | |
| Per Wold-Olsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2023 | 22,027 | 59,055 | - | - | Restricted Stock Units | |
| Per Wold-Olsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2023 | 22,027 | 171,027 (0%) | 0% | - | Ordinary Shares | |
| Murray W. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 182,433 | 182,433 | - | - | Restricted Stock Units | |
| Murray W. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 223,560 | 223,560 | - | - | Stock Option (Right to Buy) |